DRRX - DURECT Corporation Stock Trading

DURECT Corporation Announces Additional Safety Data and Efficacy Signals from Phase 1b Clinical Trial of DUR-928 in NASH Patients at The Liver Meeting Digital Experience™ 2020 PR Newswire CUPERTINO, Calif., Nov. 13, 2020 CUPERTINO, Calif. , Nov. 13, 2020...

DURECT Corporation to Host Webinar on the Treatment of Alcoholic Hepatitis Featuring Chief Medical Officer Dr. Norman Sussman PR Newswire CUPERTINO, Calif., Nov. 10, 2020 CUPERTINO, Calif. , Nov. 10, 2020 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ...

Image source: The Motley Fool. Durect Corp (NASDAQ: DRRX) Q3 2020 Earnings Call Nov 2, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: Durect Corp (DRRX) Q3 2020 Earnings Call Transcript